Join host Dr Rasha Al-Lamee in this exciting new episode, as she is joined by Prof Michael Joner and Prof Bruno Scheller to delve into the distinctive properties of two commonly utilised drugs in the field of DCB.

Increase your understanding of these products by tuning in to this enlightening 15-minute discussion, where you will gain insights on key features and the safety profile, provided with the latest updates from the FDA.

This podcast series is supported by Medtronic.

Ep 5: What is the Difference Between the Two Drugs in the Context of DCB?

DCB Unveiled: Bridging Science and Application